Sharad Ghamande, Georgia Health Sciences University (IMAGE)

Medical College of Georgia at Augusta University

Sharad Ghamande, Georgia Health Sciences University

Caption

A new strategy that takes advantage of ovarian cancer's reliance on folate appears to give relapse patients extra months of life with few side effects, according to research by Sharad Ghamande, Chief of the Section of Gynecologic Oncology at Georgia Health Sciences University.

Credit

Phil Jones, Georgia Health Sciences University Photographer

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.